Sada Sharada Tumor And Research Institute Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 26-07-2024
- Paid Up Capital ₹ 5.98 Cr
as on 26-07-2024
- Company Age 35 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.25 Cr
as on 26-07-2024
- Satisfied Charges ₹ 4.70 M
as on 26-07-2024
- Revenue 26.34%
(FY 2023)
- Profit -20.14%
(FY 2023)
- Ebitda 114.75%
(FY 2023)
- Net Worth 22.23%
(FY 2023)
- Total Assets 12.86%
(FY 2023)
About Sada Sharada Tumor And Research Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.98 Cr.
The company currently has active open charges totaling ₹4.25 Cr. The company has closed loans amounting to ₹4.70 M, as per Ministry of Corporate Affairs (MCA) records.
Anjali Ajaikumar, Basavlinga Amarkumar, Bhagya Ajaikumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110KA1989NPL009862
- Company No.
009862
- Company Classification
Public Not For Profit Company
- Incorporation Date
20 Feb 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Karnataka, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sada Sharada Tumor And Research Institute?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali Ajaikumar  | Director | 19-Mar-2018 | Current |
| Basavlinga Amarkumar | Director | 20-Feb-1989 | Current |
Bhagya Ajaikumar  | Director | 30-Sep-1993 | Current |
| Basavalinga Sadasivaiah | Director | 20-Feb-1989 | Current |
Financial Performance and Corporate Structure Insights of Sada Sharada Tumor And Research Institute.
Sada Sharada Tumor And Research Institute, for the financial year ended 2023, experienced significant growth in revenue, with a 26.34% increase. The company also saw a substantial fall in profitability, with a 20.14% decrease in profit. The company's net worth Soared by an impressive increase of 22.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sada Sharada Tumor And Research Institute?
In 2023, Sada Sharada Tumor And Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gha Global Healthcare Academy Private LimitedActive 5 years 10 daysBasavalinga Sadasivaiah is a mutual person
Bacc Health Care Private LimitedActive 22 years 10 monthsAnjali Ajaikumar and Basavalinga Sadasivaiah are mutual person
Suchirayu Health Care Solutions LimitedActive 13 years 11 monthsAnjali Ajaikumar and Basavalinga Sadasivaiah are mutual person
International Stemcell Services LimitedActive 16 years 3 monthsBasavalinga Sadasivaiah is a mutual person
Healthcare Global Enterprises LimitedActive 26 years 9 monthsAnjali Ajaikumar and Basavalinga Sadasivaiah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 14 Mar 2023 | ₹4.25 Cr | Open |
Syndicate Bank Creation Date: 26 Nov 2013 | ₹4.70 M | Satisfied |
How Many Employees Work at Sada Sharada Tumor And Research Institute?
Sada Sharada Tumor And Research Institute has a workforce of 260 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sada Sharada Tumor And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sada Sharada Tumor And Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
